Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Deferred Tax Assets / Liabilities ₹6.31 Cr₹4.98 Cr₹4.42 Cr₹4.58 Cr₹7.16 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹6.31 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹6.31 Cr
Mar2024₹4.98 Cr
Mar2023₹4.42 Cr
Mar2022₹4.58 Cr
Mar2017₹7.16 Cr

How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹6.31 Cr
26.80
Mar2024 ₹4.98 Cr
12.55
Mar2023 ₹4.42 Cr
-3.34
Mar2022 ₹4.58 Cr
-36.07
Mar2017 ₹7.16 Cr -

Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,219.2 Cr -1.2% -12.6% -24.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1.2%

-12.6%

-24.7%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses